Skip to content

Drug interactions

Safinamide + Vemurafenib

Severity: Minor

Safinamide and Vemurafenib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Vemurafenib is a BCRP substrate, and safinamide may inhibit intestinal BCRP. Vemurafenib exposure may rise slightly, with uncertain clinical significance.

What this interaction means in plain words

Safinamide and Vemurafenib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Safinamide belongs to Central Nervous System; Vemurafenib belongs to Oncology.

Evidence level: Low

Why it happens

Inhibition of intestinal BCRP efflux by safinamide may increase vemurafenib absorption.

What to do

No dose change is needed. Monitor for vemurafenib adverse effects such as rash, QT prolongation and arthralgia.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Safinamide and Vemurafenib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Safinamide with Vemurafenib?

MediHelp rates the interaction as minor. Safinamide and Vemurafenib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Vemurafenib is a BCRP substrate, and safinamide may inhibit intestinal BCRP. Vemurafenib exposure may rise slightly, with uncertain clinical significance.

How serious is the interaction between Safinamide and Vemurafenib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is needed. Monitor for vemurafenib adverse effects such as rash, QT prolongation and arthralgia.

What other medicines interact with Safinamide?

MediHelp also lists interactions of Safinamide with, for example, Amitriptyline, Amoxapine, Amphetamine polistirex. The full list is on the Safinamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in